OxyMask for delivering oxygen therapy | MIB160 | | |
Eating disorders | QS175 | | |
Asthma | QS25 | | |
Intravesical microwave hyperthermia and chemotherapy for non-muscle-invasive bladder cancer | IPG628 | | |
Inotuzumab ozogamicin for treating relapsed or refractory B-cell acute lymphoblastic leukaemia | TA541 | | |
The Vest for delivering high-frequency chest wall oscillation in people with complex neurological needs | MIB159 | | |
Chronic heart failure in adults: diagnosis and management | NG106 | | |
Preventing suicide in community and custodial settings | NG105 | | |
Emergency and acute medical care in over 16s | QS174 | | |
Leadless cardiac pacemaker implantation for bradyarrhythmias | IPG626 | | |
Superior rectal artery embolisation for haemorrhoids | IPG627 | | |
Lutetium (177Lu) oxodotreotide for treating unresectable or metastatic neuroendocrine tumours | TA539 | | |
Neon EEG electrode for EEG monitoring in newborns | MIB155 | | |
AlignRT in breast cancer radiotherapy | MIB157 | | |
Sutureless aortic valve replacement for aortic stenosis | IPG624 | | |
Flu vaccination: increasing uptake | NG103 | | |
Dinutuximab beta for treating neuroblastoma | TA538 | | |
Transurethral water vapour ablation for lower urinary tract symptoms caused by benign prostatic hyperplasia | IPG625 | | |
Intermediate care including reablement | QS173 | | |
Lenvatinib and sorafenib for treating differentiated thyroid cancer after radioactive iodine | TA535 | | |
Alectinib for untreated ALK-positive advanced non-small-cell lung cancer | TA536 | | |
Ixekizumab for treating active psoriatic arthritis after inadequate response to DMARDs | TA537 | | |
Endometriosis | QS172 | | |
Community pharmacies: promoting health and wellbeing | NG102 | | |
Dupilumab for treating moderate to severe atopic dermatitis | TA534 | | |
Low-intensity pulsed ultrasound to promote healing of fresh fractures at low risk of non-healing | IPG621 | | |
Low-intensity pulsed ultrasound to promote healing of fresh fractures at high risk of non-healing | IPG622 | | |
Low-intensity pulsed ultrasound to promote healing of delayed-union and non-union fractures | IPG623 | | |
Mechanical thrombectomy devices for acute ischaemic stroke | MIB153 | | |
Remote ECG interpretation consultancy services for cardiovascular disease | MIB152 | | |
Superior capsular augmentation for massive rotator cuff tears | IPG619 | | |
Transaxial interbody lumbosacral fusion for severe chronic low back pain | IPG620 | | |
Ocrelizumab for treating relapsing–remitting multiple sclerosis | TA533 | | |
Medicines management for people receiving social care in the community | QS171 | | |
Pembrolizumab for untreated PD-L1-positive metastatic non-small-cell lung cancer | TA531 | | |
Airglove air warming system for venous access | MIB151 | | |
Biomarker tests to help diagnose preterm labour in women with intact membranes | DG33 | | |
Nivolumab for treating locally advanced unresectable or metastatic urothelial cancer after platinum-containing chemotherapy | TA530 | | |
Spondyloarthritis | QS170 | | |
Beta interferons and glatiramer acetate for treating multiple sclerosis | TA527 | | |
Unilateral MRI-guided focused ultrasound thalamotomy for treatment-resistant essential tremor | IPG617 | | |
Laparoscopic ventral mesh rectopexy for internal rectal prolapse | IPG618 | | |
Dementia: assessment, management and support for people living with dementia and their carers | NG97 | | |
Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease | TA217 | | |
ORA G3 to measure corneal hysteresis | MIB150 | | |
Intranasal phototherapy for allergic rhinitis | IPG616 | | |
Midostaurin for untreated acute myeloid leukaemia | TA523 | | |
Brentuximab vedotin for treating CD30-positive Hodgkin lymphoma | TA524 | | |
Atezolizumab for treating locally advanced or metastatic urothelial carcinoma after platinum-containing chemotherapy | TA525 | | |
Arsenic trioxide for treating acute promyelocytic leukaemia | TA526 | | |